Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04092179 |
|---|---|
| Brief Title: | Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers |
| First Submitted : | September 13, 2019 |
| First Submitted that Met QC Criteria : | September 13, 2019 |
| First Posted : | September 17, 2019 |
| Last Update Submitted that Met QC Criteria : | January 23, 2024 |
| Last Update Posted : | January 24, 2024 |